Bert Regeer, MD
Bert Regeer, MD, has more than 30 years’ experience in clinical development and regulatory submission strategy while working at 3D and previously at some of the largest pharmaceutical companies in the world. Bert uses his expertise in clinical program design, development, and implementation to help clients prepare FDA and EMA applications as well as regulatory interactions that support product development. In his role as a senior medical executive at Roche and Bristol Myers Squibb, Bert was instrumental in designing clinical trials, obtaining approval for new indications and increasing market value for those companies. His expertise spans both small molecules and biologics in the areas of oncology, cardiology, immunology, infectious diseases, neurology and supportive care. Bert obtained his Medical Degree from Rijksuniversiteit Leiden, The Netherlands.